Home › Funds › Eagle Health Investments LP › INSM

Eagle Health Investments LP position in INSM

INSMED INC · Health Care

Eagle Health Investments LP reported holding 358,702 shares of INSM (INSMED INC) in its Q3 2026 13F filing — a position valued at US$40.9M, representing 7.38% of its reported portfolio and ranking #5 among its reported holdings. Eagle Health Investments LP has disclosed INSM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)358.70K sh
Reported value held$40.94M
Portfolio Weight7.38%
First reportedQ2 2024
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Eagle Health Investments LP's INSM position evolved

Eagle Health Investments LP first disclosed a stake in INSM in Q2 2024 at 513,700 shares (US$34.4M). The position peaked in Q2 2025 at 428,600 shares, worth US$43.1M. Across 10 filings, Eagle Health Investments LP increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 358,702 shares valued at US$40.9M — a reduction of -25,428 shares quarter over quarter.. Notable position changes include a 37% trim in Q3 2025 (shares rose 24% over the following quarter), a 71% increase in Q2 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 513.70K $34.42M New
Q3 2024 513.70K $37.50M Hold
Q4 2024 513.70K $35.47M Hold
Q1 2025 443.30K $33.82M Reduce
Q2 2025 428.60K $43.13M Reduce
Q3 2025 271.60K $39.11M Reduce
Q4 2025 210.90K $36.71M Reduce
Q1 2026 224.27K $36.67M Add
Q2 2026 384.13K $40.96M Add
Q3 2026 358.70K $40.94M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INSM and 13F data

INSM (INSMED INC) is a Health Care company. 41 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$937.8M), Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INSM

All INSM fund holders →

FAQ

How long has Eagle Health Investments LP held INSM?

Eagle Health Investments LP has disclosed INSM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Eagle Health Investments LP's current position in INSM?

As of Q3 2026, Eagle Health Investments LP holds 358.70K shares of INSM (INSMED INC), valued at $40.94M, representing 7.38% of its reported portfolio and ranking #5.

Has Eagle Health Investments LP been buying or selling INSM?

In the latest 13F filing (Q3 2026), Eagle Health Investments LP reduced its position in INSM. The position peaked in Q2 2025 at 428.60K shares.

Which other funds hold INSM?

Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Darwin Global Management, Ltd., Orbis Allan Gray Ltd, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.